# A Study to Understand the Effect and Safety of the Study Medicine PF-07817883 in Adults Who Have Symptoms of COVID-19 But Are Not Hospitalized

> **NCT05799495** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 240 (actual)

## Conditions studied

- SARS-CoV-2 Infection

## Interventions

- **DRUG:** PF-07817883
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05799495
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-23
- **Primary completion:** 2023-09-13
- **Final completion:** 2023-10-11
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2024-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05799495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05799495, "A Study to Understand the Effect and Safety of the Study Medicine PF-07817883 in Adults Who Have Symptoms of COVID-19 But Are Not Hospitalized". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05799495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*